BANK VONTOBEL/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24 Stock

Warrant

DE000VM14VU1

Market Closed - Deutsche Boerse AG 02:09:08 2024-06-12 pm EDT
0.47 EUR -20.34% Intraday chart for BANK VONTOBEL/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24
Current month+67.86%
1 month-20.34%
Date Price Change
24-06-12 0.47 -20.34%
24-06-11 0.59 -22.37%
24-06-10 0.76 +10.14%
24-06-07 0.69 +53.33%
24-06-06 0.45 +32.35%

Delayed Quote Deutsche Boerse AG

Last update June 12, 2024 at 02:09 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VM14VU
ISINDE000VM14VU1
Date issued 2023-09-06
Strike 100 $
Maturity 2024-06-21 (9 Days)
Parity 10 : 1
Emission price 0.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.13
Lowest since issue 0.25
Spread 0.01
Spread %2.13%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.4 USD
Average target price
125.4 USD
Spread / Average Target
+20.11%
Consensus